We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protagen, Inova Announce Agreement for BICD2 Biomarker

News   Aug 12, 2016

 
Protagen, Inova Announce Agreement for BICD2 Biomarker
 
 
 

RELATED ARTICLES

Immune System Kept in Check by Protein Police

News

Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression.

READ MORE

Cervical Cancer Test Has 100% Detection Rate

News

A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study led by Queen Mary University of London.

READ MORE

3D Printed Microfluidic Device Simulates Cancer Treatments

News

Inexpensive 3-D-printed microfluidics device could be used to personalize cancer treatment. A key feature in this MIT-designed device was using a new biocompatible resin — traditionally used for dental applications — that can support long-term survival of biopsied tissue.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE